Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Repligen Corporation - Common Stock
(NQ:
RGEN
)
142.08
-3.26 (-2.24%)
Streaming Delayed Price
Updated: 1:30 PM EDT, Jul 29, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
614,978
Open
144.24
Bid (Size)
141.82 (100)
Ask (Size)
142.42 (200)
Prev. Close
145.34
Today's Range
142.08 - 149.73
52wk Range
100.99 - 175.77
Shares Outstanding
55,679,964
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Repligen (RGEN) Stock Is Up Today
July 28, 2026
What Happened? Shares of biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) jumped 14.6% in the afternoon session after the company reported ...
Via
StockStory
Topics
Artificial Intelligence
Repligen Q2 Earnings Call Highlights
↗
July 28, 2026
Repligen (NASDAQ:RGEN) reported second-quarter 2026 revenue of $204 million, up 12% year over year on a reported basis and 13% organically, as demand for proteins, analytics products and recurring...
Via
MarketBeat
Topics
Earnings
Performance
YTD
-13.6%
-13.6%
1 Month
+3.7%
+3.7%
3 Month
+21.0%
+21.0%
6 Month
-13.2%
-13.2%
1 Year
+18.7%
+18.7%
More News
Read More
Which stocks are gapping on Tuesday?
↗
July 28, 2026
Via
Chartmill
Repligen (NASDAQ:RGEN) Rallies as Quality Stock Delivers Earnings Beat
↗
July 28, 2026
Via
Chartmill
Repligen (NASDAQ:RGEN) Posts Better-Than-Expected Sales In Q2 CY2026
July 28, 2026
Via
StockStory
Repligen Corp (NASDAQ:RGEN) Sees Pre-Market Gain After Q1 Earnings Beat Offsets Slight Revenue Miss
↗
May 05, 2026
Via
Chartmill
Topics
Earnings
Repligen (RGEN) Q2 Earnings: What To Expect
July 26, 2026
Via
StockStory
Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know
July 24, 2026
Via
StockStory
3 Cash-Producing Stocks That Concern Us
July 24, 2026
Via
StockStory
Repligen to Buy BioLife Solutions for $1.5 Billion, Expanding Cell Therapy Reach
↗
July 22, 2026
Via
MarketBeat
Why Repligen (RGEN) Stock Is Trading Lower Today
July 21, 2026
Via
StockStory
3 Reasons RGEN is Risky and 1 Stock to Buy Instead
July 08, 2026
Via
StockStory
Topics
Stocks
Supply Chain
2 High-Flying Stocks on Our Watchlist and 1 We Find Risky
June 25, 2026
Via
StockStory
2 Profitable Stocks on Our Watchlist and 1 Facing Challenges
June 19, 2026
Via
StockStory
3 Out-of-Favor Stocks We Keep Off Our Radar
May 22, 2026
Via
StockStory
Q1 Rundown: Repligen (NASDAQ:RGEN) Vs Other Drug Development Inputs & Services Stocks
May 18, 2026
Via
StockStory
Why Repligen (RGEN) Stock Is Trading Up Today
May 15, 2026
Via
StockStory
Topics
Artificial Intelligence
Economy
1 Growth Stock with Explosive Upside and 2 Facing Headwinds
May 15, 2026
Via
StockStory
Repligen, AdaptHealth, and IQVIA Stocks Trade Down, What You Need To Know
May 13, 2026
Via
StockStory
Topics
Economy
5 Revealing Analyst Questions From Repligen’s Q1 Earnings Call
May 12, 2026
Via
StockStory
Topics
Earnings
3 Small-Cap Stocks We Steer Clear Of
May 12, 2026
Via
StockStory
Repligen (RGEN) Shares Skyrocket, What You Need To Know
May 05, 2026
Via
StockStory
Topics
Artificial Intelligence
Earnings
Regulatory Compliance
Repligen (RGEN) Q1 2026 Earnings Call Transcript
↗
May 05, 2026
Via
The Motley Fool
Topics
Earnings
Repligen’s (NASDAQ:RGEN) Q1 CY2026 Sales Beat Estimates
May 05, 2026
Via
StockStory
Topics
Earnings
Repligen (RGEN) Q1 Earnings Report Preview: What To Look For
May 03, 2026
Via
StockStory
Topics
Artificial Intelligence
Frequently Asked Questions
Is Repligen Corporation - Common Stock publicly traded?
Yes, Repligen Corporation - Common Stock is publicly traded.
What exchange does Repligen Corporation - Common Stock trade on?
Repligen Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Repligen Corporation - Common Stock?
The ticker symbol for Repligen Corporation - Common Stock is RGEN on the Nasdaq Stock Market
What is the current price of Repligen Corporation - Common Stock?
The current price of Repligen Corporation - Common Stock is 142.08
When was Repligen Corporation - Common Stock last traded?
The last trade of Repligen Corporation - Common Stock was at 07/29/26 01:30 PM ET
What is the market capitalization of Repligen Corporation - Common Stock?
The market capitalization of Repligen Corporation - Common Stock is 7.91B
How many shares of Repligen Corporation - Common Stock are outstanding?
Repligen Corporation - Common Stock has 8B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.